Related Experiment Video
Updated: Jul 11, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Microbe-derived uremic solutes enhance thrombosis potential in the host
Ina Nemet1,2, Masanori Funabashi3,4,5, Xinmin S Li1,2
1Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland, Ohio, USA.
Gut microbes produce toxins linked to cardiovascular disease. We identified specific microbial genes that generate these toxins, demonstrating their role in disease risk and a pro-thrombotic state in vivo.
Area of Science:
- Microbiology
- Cardiovascular Disease Research
- Metabolomics
Background:
- Gut microbial metabolites are increasingly recognized for their role in host health and disease.
- Elevated levels of certain microbial products, such as p-cresol sulfate and indoxyl sulfate, are associated with increased cardiovascular disease (CVD) risk.
- Understanding the specific microbial pathways that generate these harmful molecules is crucial for developing targeted therapies.
Purpose of the Study:
- To link blood levels of microbial products to cardiovascular disease risks using clinical data.
- To identify the specific gut microbes and enzymes responsible for producing detrimental uremic toxins.
- To establish a causal link between microbial genes, toxin production, and adverse host phenotypes in vivo.
Main Methods:
- Large-scale clinical data analysis to correlate microbial product levels with CVD risk and mortality.
- Metagenomic and enzymatic analysis to identify microbes and genes involved in p-cresol and indole production.
- Germ-free mouse models colonized with specific microbial genes to assess in vivo toxin formation and pro-thrombotic effects.
Main Results:
- Clinical observations linked specific microbial products to significant 5-year mortality risks in cardiovascular patients.
- Identified key microbial genes responsible for generating p-cresol and indole, precursors to p-cresol sulfate and indoxyl sulfate.
- Demonstrated that these microbial genes are sufficient to cause the formation of these uremic toxins and induce a pro-thrombotic phenotype in vivo.
Conclusions:
- Gut microbial pathways producing p-cresol and indole are directly implicated in cardiovascular disease risk.
- The identified microbial genes and bioengineered tools provide a foundation for targeting these pathways therapeutically.
- This study establishes a critical link between gut microbial metabolism, uremic toxin production, and cardiovascular pathophysiology.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Urinary Tract Infection II: Pathophysiology
Nephrotic Syndrome I : Introduction
Venous Thrombosis I: Introduction
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Gene Regulation in Microbial Communities: Quorum Sensing

